Phase 2 Open-label Study of Alum-adjuvanted Chikungunya Virus-like Particle Vaccine (PXVX0317)
Clinical trial NCT03992872 · COMPLETED
Trial details
- NCT number
- NCT03992872
- Sponsor
- Bavarian Nordic
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-20
- Primary completion
- 2021-01-19
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.